FindTrial
Sign In

Gene expression study on Osteoarthritis of knee treated with Bryonia alba 200

Effect of Bryonia Alba 200th Potencys Role In Altering The Gene Expression On Hyaluronan Synthase 2 Gene of The Patients With Clinical manifestation of Osteoarthritis Knee - GEBA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033219
Enrollment
30
Registered
2021-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M17- Osteoarthritis of knee

Interventions

Intervention1: Bryonia alba 200: Bryonia Alba 200 2 grain lactose given every 6 hours orally for 90 days Control Intervention1: Not Applicable: Not Applicable

Sponsors

Sarada Krishna Homoeopathic Medical College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who indicate the symptoms of Bryonia Alba especially in osteoarthritis.

Exclusion criteria

Exclusion criteria: Patients suffering from other severe systemic diseases. Age below 45 and above 70 years. Patient for whom Bryonia Alba is not the indicated medicine.

Design outcomes

Primary

MeasureTime frame
Bryonia alba has effect on Hyaluronan synthase 2 gene. Homoeopathic remedies have the potential to alter the gene expression.Timepoint: 2 weeks—

Secondary

MeasureTime frame
Homoeopathic remedies have the potential to alter the gene expression.Timepoint: 2 weeks—

Countries

India

Contacts

Public ContactShandic Kumar S

Sarada Krishna Homoeopathic Medical College And Hospital

drwinstonv@gmail.com9443692478

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026